[Research progress on brucellosis combined with liver injury]. [PDF]
Ibrahim D, Lu XB.
europepmc +1 more source
[Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens]. [PDF]
Hou YH, Zhang LY.
europepmc +1 more source
[Sounding the call for functional cure of hepatitis B and opening a new era of combination therapy]. [PDF]
Cheng C, Liang XE, Liu ZH, Hou JL.
europepmc +1 more source
[Altered oral microbiome and metabolites are associated with improved lipid metabolism in HBV-infected patients with metabolic dysfunction-associated fatty liver disease]. [PDF]
Zhang J +9 more
europepmc +1 more source
[Research progress on the impact of metabolic associated fatty liver disease on viral activity, treatment response, and prognosis in patients with chronic hepatitis B: current status and prospects]. [PDF]
Gong H, Zhao TT, Huang M, Liu CC, He N.
europepmc +1 more source
[Predictive role of dynamic changes in liver stiffness measurement for liver-related endpoint events in chronic hepatitis B]. [PDF]
Sun CL +10 more
europepmc +1 more source
[Clinical practice and challenges from simple models to precise integration for serological evaluation of a non-invasive diagnosis of liver fibrosis]. [PDF]
Jin R, Ni WJ, Rui FJ, Li J.
europepmc +1 more source
[The concept of a fountional cure for hepatitis B keeps pace with the times]. [PDF]
Liu ZH, Liang XE.
europepmc +1 more source
[Dynamic changes of HBsAb and its predictive value in patients with chronic hepatitis B receiving antiviral therapy for clinical cure]. [PDF]
Yang HY +10 more
europepmc +1 more source
[Role of serum Golgi protein 73 in the assessment of pathological prognosis and its inflammatory influencing factors for hepatitis B virus-related liver fibrosis]. [PDF]
Fan HN +5 more
europepmc +1 more source

